Pictet North America Advisors SA Has $4.14 Million Holdings in CME Group Inc. $CME

Key Points

• Pictet North America Advisors has reduced its holdings in CME Group Inc. by 9.4%, bringing its stake down to 15,019 shares, valued at approximately $4.14 million.
• Institutional investors and hedge funds hold a significant majority, owning 87.75% of CME Group's stock, highlighting strong institutional interest in the company.
• Recent analyst reports have adjusted price targets for CME Group, with Citigroup raising its target from $265 to $275 and UBS Group lowering theirs from $305 to $285, suggesting mixed outlooks from market analysts.

Pictet North America Advisors SA decreased its position in CME Group Inc. (NASDAQ:CME - Free Report) by 9.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,019 shares of the financial services provider's stock after selling 1,558 shares during the quarter. Pictet North America Advisors SA's holdings in CME Group were worth $4,140,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in CME. Vanguard Group Inc. lifted its stake in shares of CME Group by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider's stock valued at $9,190,661,000 after acquiring an additional 400,737 shares during the last quarter. Raymond James Financial Inc. grew its holdings in CME Group by 9.7% during the 1st quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider's stock worth $1,091,401,000 after acquiring an additional 363,130 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of CME Group by 29.9% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider's stock valued at $747,744,000 after buying an additional 648,591 shares during the period. AQR Capital Management LLC grew its stake in shares of CME Group by 10.3% in the 1st quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider's stock valued at $735,539,000 after buying an additional 260,065 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of CME Group by 11.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,727,809 shares of the financial services provider's stock valued at $723,660,000 after buying an additional 290,147 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

Analysts Set New Price Targets

CME has been the topic of several recent analyst reports. Citigroup lifted their target price on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Barclays set a $298.00 price target on shares of CME Group and gave the company an "equal weight" rating in a research report on Thursday, July 24th. Wall Street Zen cut CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. UBS Group decreased their price target on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research note on Monday, September 8th. Finally, Piper Sandler lifted their target price on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $260.60.

Insider Buying and Selling at CME Group

In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of the company's stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the company's stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,043 shares of company stock valued at $3,527,956. Corporate insiders own 0.30% of the company's stock.

CME Group Stock Performance

Shares of CME stock opened at $261.08 on Tuesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a fifty day moving average price of $271.66 and a 200 day moving average price of $270.86. The company has a market cap of $94.09 billion, a P/E ratio of 25.27, a PEG ratio of 4.73 and a beta of 0.43. CME Group Inc. has a 12 month low of $212.60 and a 12 month high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.56 earnings per share. Sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be given a $1.25 dividend. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group's payout ratio is presently 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.